NO974371L - Epitelialadhesive lactobacilli - Google Patents
Epitelialadhesive lactobacilliInfo
- Publication number
- NO974371L NO974371L NO974371A NO974371A NO974371L NO 974371 L NO974371 L NO 974371L NO 974371 A NO974371 A NO 974371A NO 974371 A NO974371 A NO 974371A NO 974371 L NO974371 L NO 974371L
- Authority
- NO
- Norway
- Prior art keywords
- mannose
- plantarum
- specific
- lactobacilli
- pharmaceutical composition
- Prior art date
Links
- 241000186660 Lactobacillus Species 0.000 title 1
- 239000000853 adhesive Substances 0.000 title 1
- 230000001070 adhesive effect Effects 0.000 title 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 abstract 4
- 240000006024 Lactobacillus plantarum Species 0.000 abstract 4
- 235000013965 Lactobacillus plantarum Nutrition 0.000 abstract 2
- 244000052616 bacterial pathogen Species 0.000 abstract 2
- 229940072205 lactobacillus plantarum Drugs 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 229920000936 Agarose Polymers 0.000 abstract 1
- 206010070545 Bacterial translocation Diseases 0.000 abstract 1
- 201000001579 bacterial gastritis Diseases 0.000 abstract 1
- 230000007375 bacterial translocation Effects 0.000 abstract 1
- 239000011324 bead Substances 0.000 abstract 1
- 238000009109 curative therapy Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 210000002919 epithelial cell Anatomy 0.000 abstract 1
- 108010037896 heparin-binding hemagglutinin Proteins 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Denne oppfinnelse vedrører anvendelse av Lactobacillus plantarum som har et mannosespesifikt adhesin for fremstilling av en farmasøytisk blanding som inhiberer bindingen av patogene bakterier som uttrykker mannose-spesifikke adhesiner, til epitelcelleoverflaten. En stamme av Lactobacillus plantarum som kan anvendes i denne oppfinnelse, vil klebe til mannosebelagte agaroseperler, og tilhører fortrinnsvis en klynge av L. plantarum med mer enn 70% likhet med L. plantarum 299 med hensyn til REA. Oppfinnelsen refererer også til anvendelsen av nevnte stammer for fremstilling av en farmasøytisk blanding for anvendelse i profylaktisk eller kurativ behandling av bakteriell translokasjon, magekatarr og andre syk-dommer forårsaket av patogene bakterier som uttrykker mannosespesifikke adhesiner.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9501056A SE9501056D0 (sv) | 1995-03-23 | 1995-03-23 | Epithelial adherent lactobacilli |
PCT/SE1996/000372 WO1996029083A1 (en) | 1995-03-23 | 1996-03-25 | Epithelial adhesive lactobacilli |
Publications (2)
Publication Number | Publication Date |
---|---|
NO974371D0 NO974371D0 (no) | 1997-09-22 |
NO974371L true NO974371L (no) | 1997-11-20 |
Family
ID=20397666
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO974371A NO974371L (no) | 1995-03-23 | 1997-09-22 | Epitelialadhesive lactobacilli |
Country Status (17)
Country | Link |
---|---|
US (1) | US6159465A (no) |
EP (1) | EP0817640B1 (no) |
JP (1) | JP4072646B2 (no) |
KR (1) | KR100446482B1 (no) |
CN (1) | CN1138551C (no) |
AT (1) | ATE240738T1 (no) |
AU (1) | AU702705B2 (no) |
BR (1) | BR9607538A (no) |
CA (1) | CA2216150C (no) |
DE (1) | DE69628288T2 (no) |
EE (1) | EE04097B1 (no) |
ES (1) | ES2200057T3 (no) |
HK (1) | HK1017989A1 (no) |
NO (1) | NO974371L (no) |
PL (1) | PL184037B1 (no) |
SE (1) | SE9501056D0 (no) |
WO (1) | WO1996029083A1 (no) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100376954B1 (ko) * | 1995-07-31 | 2003-07-18 | 프로비 에이비 | 장에서집락화하는유산간균 |
FI974643A (fi) * | 1997-12-30 | 1999-07-01 | Atria Oyj | Biologinen menetelmä salmonellan eliminoimiseksi prosesseista ja rakenteista |
KR20010075495A (ko) * | 1998-10-01 | 2001-08-09 | 추후보정 | 산화성 스트레스 인자의 감소 |
WO2001010448A1 (en) * | 1999-08-09 | 2001-02-15 | University Of Maryland, Baltimore | Pro-gut maturation and anti-inflammatory effects of lactobacillus and lactobacillus secreted proteins, carbohydrates and lipids |
EP1227827B1 (en) | 1999-10-26 | 2005-03-09 | Societe Des Produits Nestle S.A. | Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis |
GB2369777B (en) * | 2000-10-05 | 2004-10-27 | St Ivel Ltd | Food products with antimicrobial lactic acid bacteria |
SE0004124D0 (sv) * | 2000-11-10 | 2000-11-10 | Probi Ab | New use |
FR2831555A1 (fr) * | 2001-10-29 | 2003-05-02 | Ceva Sante Animale | Procede de selection de souches de bacteries lactiques a gram positif non pathogenes capables de lutter contre des infections par des bacteries pathogenes |
HUP0400199A3 (en) * | 2001-06-14 | 2005-06-28 | Ceva Sante Animale | Method of selecting non-pathogenic gram-positive lactic acid bacteria strains |
FR2826020B1 (fr) * | 2001-06-14 | 2005-02-11 | Ceva Sante Animale | Procede de selection de souches de bacteries lactiques a gram positif non pathogenes capables de lutter contre des infections par des bacteries pathogenes |
SE527555C2 (sv) * | 2003-04-04 | 2006-04-11 | Probi Ab | Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar |
WO2005086870A2 (en) * | 2004-03-10 | 2005-09-22 | The Board Of Trustees Of The University Of Illinois | Novel lactobacillus strains and method of use |
DE602005020915D1 (de) * | 2004-03-23 | 2010-06-10 | Friesland Brands Bv | Mannose-spezifische adhesinen und deren vervendung |
SE528382C2 (sv) * | 2004-10-05 | 2006-10-31 | Probi Ab | Probiotiska lactobacillusstammar för förbättrad vaginal hälsa |
JP2006180836A (ja) * | 2004-12-28 | 2006-07-13 | Marudai Food Co Ltd | 食中毒菌感染を抑制する乳酸菌、ならびにそれを含む発酵物、食品および医薬組成物 |
JP2006257077A (ja) * | 2005-02-18 | 2006-09-28 | Marudai Food Co Ltd | 免疫調節剤および免疫調節食品 |
CN1888051B (zh) * | 2005-06-28 | 2010-05-05 | 北京天佑达生物工程科技有限公司 | 一株植物乳杆菌及其应用 |
SE529199C2 (sv) * | 2005-07-05 | 2007-05-29 | Probi Ab | Förstärkt absorption |
AU2006296837B2 (en) | 2005-09-28 | 2012-12-13 | Nordic Rebalance A/S | Treatment of IBD and IBS using both probiotic bacteria and fermented cereal as treatment effectors |
CA2630823C (en) | 2005-12-13 | 2015-02-10 | Exthera Ab | Method for extracorporeal removal of a pathogenic microbe, an inflammatory cell or an inflammatory protein from blood |
PL210465B1 (pl) | 2007-06-04 | 2012-01-31 | Inst Biotechnologii Surowic I Szczepionek Biomed Społka Akcyjna | Zastosowanie kompozycji szczepów z rodzaju Lactobacillus |
FR2928935B1 (fr) | 2008-03-19 | 2011-05-20 | Gervais Danone Sa | Souche de lactobacillus rhamnosus. |
US9259447B2 (en) | 2009-07-30 | 2016-02-16 | Dupont Nutrition Biosciences Aps | Lactic acid bacteria and bifidobacteria for treating endotoxemia |
US8758286B2 (en) | 2009-12-01 | 2014-06-24 | Exthera Medical Corporation | Method for removing cytokines from blood with surface immobilized polysaccharides |
RU2563525C2 (ru) | 2010-01-28 | 2015-09-20 | Аб-Биотикс С.А. | Пробиотическая композиция для применения в лечении воспаления кишечника |
WO2012112724A1 (en) | 2011-02-15 | 2012-08-23 | Exthera Medical, Llc | Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines |
BG66608B1 (bg) * | 2011-05-04 | 2017-10-16 | "Ел Би Булгарикум" ЕАД | Полибактериален пробиотичен препарат |
CN102618456B (zh) * | 2012-02-28 | 2013-08-21 | 江南大学 | 一种能够缓解慢性酒精性肝损伤的鼠李糖乳杆菌及其用途 |
DK2861273T3 (da) | 2012-06-13 | 2017-11-27 | Exthera Medical Corp | Anvendelse af heparin og kulhydrater til behandling af cancer. |
JP2012184261A (ja) * | 2012-06-21 | 2012-09-27 | Snow Brand Milk Products Co Ltd | 免疫増強剤 |
CN102827796B (zh) * | 2012-09-03 | 2013-10-30 | 江南大学 | 一种具有排镉功能的植物乳杆菌及其用途 |
EP2897638A1 (en) | 2012-09-24 | 2015-07-29 | Montana State University-Bozeman | Recombinant lactococcus lactis expressing escherichia coli colonization factor antigen i (cfa/i) fimbriae and their methods of use |
WO2014209782A1 (en) | 2013-06-24 | 2014-12-31 | Exthera Medical Corporation | Blood filtration system containing mannose coated substrate |
CN105705177B (zh) | 2013-11-08 | 2019-10-22 | 艾克塞拉医疗公司 | 使用吸附介质诊断感染性疾病的方法 |
DE15782250T1 (de) | 2014-04-24 | 2017-08-10 | Exthera Medical Corporation | Verfahren zur Entfernung von Bakterien aus Blut unter Verwendung einer hohen Durchflussrate |
CA2959975A1 (en) | 2014-09-22 | 2016-03-31 | Exthera Medical Corporation | Wearable hemoperfusion device |
KR102587444B1 (ko) | 2015-09-29 | 2023-10-11 | 킴벌리-클라크 월드와이드, 인크. | 미생물총의 건강한 균형을 유지하기 위한 상승 조성물 |
WO2017151797A1 (en) | 2016-03-02 | 2017-09-08 | Exthera Medical Corporation | Method for treating drug intoxication |
US11911551B2 (en) | 2016-03-02 | 2024-02-27 | Exthera Medical Corporation | Method for treating drug intoxication |
KR20190120235A (ko) | 2017-02-28 | 2019-10-23 | 킴벌리-클라크 월드와이드, 인크. | 미생물총의 건강한 균형을 유지하기 위한 상승적 조성물 |
WO2019103198A1 (ko) | 2017-11-24 | 2019-05-31 | 주식회사 고바이오랩 | 락토바실러스 퍼멘텀 kbl 375 균주 및 그 용도 |
WO2019216662A1 (ko) | 2018-05-09 | 2019-11-14 | 주식회사 고바이오랩 | 락토바실러스 파라카제이 균주 및 그 용도 |
AU2019274351B2 (en) | 2018-05-23 | 2022-04-07 | Kobiolabs, Inc. | Lactobacillus gasseri KBL697 strain and use thereof |
JP2022534191A (ja) | 2019-05-16 | 2022-07-28 | エクスセラ メディカル コーポレイション | 内皮糖衣構造を調節するための方法 |
US20220226382A1 (en) | 2019-06-05 | 2022-07-21 | Morinaga Milk Industry Co., Ltd. | Nutritional Composition |
CN111575223B (zh) * | 2020-05-20 | 2022-04-15 | 江南大学 | 一种降低鼠李糖乳杆菌表面物质分泌量的方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GR861387B (en) * | 1985-05-29 | 1986-10-02 | Pioneer Hi Bred Int | Method of treating gastrointestinal disease in animals |
SE469875C (sv) * | 1991-07-25 | 1997-04-14 | Probi Ab | Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen |
GB9124249D0 (en) * | 1991-11-14 | 1992-01-08 | Goldstein Fredric | Ribbon curling and shredding device |
GB2261372A (en) * | 1991-11-15 | 1993-05-19 | Gregor Reid | Lactobacillus and skim milk compositions for prevention of urogenital infection |
-
1995
- 1995-03-23 SE SE9501056A patent/SE9501056D0/xx unknown
-
1996
- 1996-03-25 BR BR9607538A patent/BR9607538A/pt not_active Application Discontinuation
- 1996-03-25 EP EP96908428A patent/EP0817640B1/en not_active Expired - Lifetime
- 1996-03-25 CN CNB961940867A patent/CN1138551C/zh not_active Expired - Lifetime
- 1996-03-25 CA CA002216150A patent/CA2216150C/en not_active Expired - Lifetime
- 1996-03-25 US US08/913,618 patent/US6159465A/en not_active Expired - Lifetime
- 1996-03-25 JP JP52834796A patent/JP4072646B2/ja not_active Expired - Lifetime
- 1996-03-25 KR KR1019970706504A patent/KR100446482B1/ko not_active IP Right Cessation
- 1996-03-25 ES ES96908428T patent/ES2200057T3/es not_active Expired - Lifetime
- 1996-03-25 WO PCT/SE1996/000372 patent/WO1996029083A1/en active IP Right Grant
- 1996-03-25 AU AU51665/96A patent/AU702705B2/en not_active Expired
- 1996-03-25 EE EE9700329A patent/EE04097B1/xx unknown
- 1996-03-25 AT AT96908428T patent/ATE240738T1/de active
- 1996-03-25 DE DE69628288T patent/DE69628288T2/de not_active Expired - Lifetime
- 1996-03-25 PL PL96322550A patent/PL184037B1/pl unknown
-
1997
- 1997-09-22 NO NO974371A patent/NO974371L/no not_active Application Discontinuation
-
1998
- 1998-10-19 HK HK98111312A patent/HK1017989A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2216150C (en) | 2008-01-22 |
DE69628288D1 (de) | 2003-06-26 |
AU702705B2 (en) | 1999-03-04 |
EP0817640B1 (en) | 2003-05-21 |
EE04097B1 (et) | 2003-08-15 |
AU5166596A (en) | 1996-10-08 |
CN1138551C (zh) | 2004-02-18 |
KR100446482B1 (ko) | 2006-01-27 |
EE9700329A (et) | 1998-06-15 |
KR19980703102A (ko) | 1998-10-15 |
JP4072646B2 (ja) | 2008-04-09 |
US6159465A (en) | 2000-12-12 |
DE69628288T2 (de) | 2004-04-08 |
PL322550A1 (en) | 1998-02-02 |
SE9501056D0 (sv) | 1995-03-23 |
WO1996029083A1 (en) | 1996-09-26 |
NO974371D0 (no) | 1997-09-22 |
ES2200057T3 (es) | 2004-03-01 |
PL184037B1 (pl) | 2002-08-30 |
EP0817640A1 (en) | 1998-01-14 |
ATE240738T1 (de) | 2003-06-15 |
HK1017989A1 (en) | 1999-12-10 |
BR9607538A (pt) | 1998-01-06 |
JPH11502703A (ja) | 1999-03-09 |
CN1185111A (zh) | 1998-06-17 |
CA2216150A1 (en) | 1996-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO974371L (no) | Epitelialadhesive lactobacilli | |
Ogawa et al. | Inhibition of Streptococcus mutans biofilm formation by Streptococcus salivarius FruA | |
Jensen et al. | In vitro testing of commercial and potential probiotic lactic acid bacteria | |
Bleau et al. | Intermediate chains of exopolysaccharides from Lactobacillus rhamnosus RW‐9595M increase IL‐10 production by macrophages | |
Ocaña et al. | Vaginal lactobacilli: self-and co-aggregating ability | |
EP1816190B1 (en) | New lactic bacteria useful as probiotics | |
Lara-Hidalgo et al. | Isolation of yeasts from guajillo pepper (Capsicum annuum L.) fermentation and study of some probiotic characteristics | |
Wang et al. | Survival of Lactobacillus casei strain Shirota in the intestines of healthy Chinese adults | |
HUP9901619A1 (hu) | Streptococcus thermophilus és bifidobacterium longum baktériumokat tartalmazó enterális diétás kompozíciók és azok alkalmazása | |
NO306699B1 (no) | Tarmkanal-koloniserende lactobasiller, samt fremgangsmåte for isolering og anvendelse derav, samt blanding | |
EP1624762B1 (en) | A probiotic composition comprising at least two lactic acid bacterial strains which are able to colonise the gastrointestinal tracts in combination with having intestinal survival property, intestinal binding property, an infection protection property and a fiber fermenting property | |
MXPA04000808A (es) | Cepas probioticas de lactobacillus salivarius. | |
WO2002083879A3 (en) | Immunotherapy based on dendritic cells | |
Mu et al. | Probiotic yeast BR14 ameliorates DSS-induced colitis by restoring the gut barrier and adjusting the intestinal microbiota | |
CA3027458A1 (en) | Dermatological preparations for maintaining and/or restoring healthy skin microbiota | |
Tzvetkova et al. | Hydrolysis of major dairy proteins by lactic acid bacteria from Bulgarian yogurts | |
Yadav et al. | Adhesion of indigenous Lactobacillus plantarum to gut extracellular matrix and its physicochemical characterization | |
NZ335086A (en) | Bacillus thuringiensis pesticidal toxins and nucleotide sequences which encode these toxins | |
WO2011018080A2 (de) | Zusammensetzung mit stämmen von lactobazillus fermentum | |
Yang et al. | Study of the probiotic properties of lactic acid bacteria isolated from Chinese traditional fermented pickles | |
US5468479A (en) | Compositions containing lactic acid bacterium Streptococcus salivarius | |
WO2022234511A3 (en) | Compositions comprising bacterial strains for treatment of diseases associated with alterations in glucose metabolism | |
AL-Saeedi et al. | Bacteriocin from Streptococcus salivarius optimized statistically by response surface methodology active against different clinical oral pathogenic Streptococci | |
Englerová et al. | The study of the probiotic potential of the beneficial bacteria isolated from kefir grains | |
WO2023281415A3 (en) | Bacteria strains for topical skin care |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |